Resources for coping with cancer during COVID-19. Learn More

Prostate Cancer Metastasis: Tracking and Targeting an Elusive Enemy

Speaker: Dr. Alison Allan
Original Date: Tuesday May 5, 2015
The majority of prostate cancer deaths are cause by the spread of tumour cells from the original prostate tumour to distant sites in the body, a process called metastasis. The ability to find, track and understand metastasis in cancer patients remains one of the greatest challenges in cancer treatment.

In this Expert Angle webinar Dr. Alison Allan describes the current knowledge about metastasis and the exciting developments in blood-based biomarker tests that may help find metastatic disease earlier and provide important information for effective, personalized treatment of prostate cancer.

Speaker – Dr. Alison Allan

15EGD-DrAllan.jpgDr. Alison Allan is a Senior Oncology Scientist and the Basic Science Co-Lead of the Metastasis Translational Cancer Research Team at the London Regional Cancer Program; and an Associate Professor of Oncology and Anatomy & Cell Biology at Western University in London, Ontario. Dr. Allan’s research program is focussed on cellular and molecular mechanisms of cancer metastasis; in particular the study of circulating tumour cells and cancer stem cells in patients and animal models. She has been the recipient of Prostate Cancer Canada research funding for her work in understanding circulating tumour cells in prostate cancer, and for the development of new blood-based biomarker tests to better track metastasis in prostate cancer patients.

Dr. Alison Allan can be reached at:

Cancer Research Laboratory Program
London Regional Cancer Program, London Health Sciences Centre
Victoria Research Labs, Room A4-132
London, Ontario
Canada N6A 4L6

Tel: 519.685.8600 Ext. 55134
Fax: 519.685.8616
Email: alison.allan@lhsc.on.ca

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

Rock the Road Raffle 2021

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Canadian Cancer Society and Prostate Cancer Canada celebrate their amalgamation

February 3, 2020 (Toronto, ON) – On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation.

1.5 million Canadian men over 50 now at unnecessary risk for prostate cancer

Toronto (ON) – September 26, 2019 – New findings released today in a Prostate Cancer Canada nationwide survey suggest 1.

$2 million invested in new prostate cancer research

Prostate Cancer Canada and Movember partner to fund ten research projects breaking new ground

Dream car draw a win for all Ontarians affected by prostate cancer

February 22, 2019 – TORONTO, ON – A dream came true today for Harold Mutter (ticket #19273), the lucky winner of a 2018 Acura NSX valued at more than $235,000 - the prize for Prostate Cancer Canada’s seventh Rock the Road Raffle.

Click here for news archive